FaceHeart CardioMirror, the first AI-powered smart mirror for cardiac health assessments developed by FaceHeart Corp., has been honored with the Innovation Award Honoree in the Digital Health category at CES 2025.
November 20, 2024
The CES Innovation Awards program is an annual competition honoring outstanding design and engineering in 29 consumer technology. The program is owned and produced by the Consumer Technology Association (CTA) ®. Among 3,000 submission, FaceHeart stands out once again as one of the 44 honorees in Digital Health.
The announcement of the honoree list was made ahead of CES 2025, the prominent technology event happening in January 7-10 in Las Vegas USA. FaceHeart has the privilege of attending the CES Unveil, an exclusive event for honorees two days ahead of CES.
%20(1086%20x%20658%20%E5%83%8F%E7%B4%A0).png)
Empowering Individuals in Cardiovascular Disease Screening
As a CES honoree in Digital Health, FaceHeart has been striving to improve health outcome with our innovative and contact-free technology. FaceHeart CardioMirror is the first AI-powered smart mirror for cardiac health assessments, offering a 45-second “selfie” that detects vital signs such as Heart Rate (HR), Blood Pressure (BP), Respiration Rate (RR), Oxygen Saturation (SpO2), Heart Rate Variability (HRV), and Stress Index along with cardiac signs – Atrial Fibrillation (AFib) and Heart Failure (HF) with 90% accuracy. Leveraging its FDA-cleared in Heart Rate measurement with remote photoplethysmography (rPPG) methodology and deep learning models, it enables contactless vital sign detection from facial video.
FaceHeart CardioMirror demonstrates FaceHeart’s resolution in providing a better solution to wellbeing. Integrated with our FDA-cleared rPPG solution, FaceHeart Vitals™, the mirror demonstrates the capability of this software development kit (SDK) to adapt to measurements across various devices. Using a simple camera, FaceHeart Vitals™ brings contactless vital sign measurement into the hands of individuals, empowering telemedicine, remote patient monitoring, digital therapy, and decentralized clinical trials to monitor end-users' health status.
By reducing the risk of long-term complications and lowering emergency care costs, it enhances public health, ensuring better cardiovascular disease screening and management intelligently.
Laying the Cornerstone in Preventive Healthcare
Receiving the CES Innovation Award Honoree in 2025 is once another testimonial to FaceHeart. This recognition follows the previous Innovation Award at CES 2024: FaceHeart Vitals™, the SDK that can be integrated with various devices to empower telemedicine, RPM, DTx, and decentralized clinical trials to monitor end-users' health status. In the meantime, FaceHeart has developed using 200M datasets from 5000 testers and built solid partnerships around the world, dedicating in making an impact on the empowerment in health management and prevention.
FaceHeart will continue developing solutions that benefit a wide range of people in healthcare ecosystem, redefining the future of healthcare to be more accessible and effective.
For more information, please leave your contact here or send us an email via [email protected]
